Daniel Zingg

In 2018, I joined the lab of Jos Jonkers as postdoctoral fellow to study molecular mechanisms contributing to the initiation of invasive lobular breast cancer using genome-wide forward genetic screening in murine mammary epithelial cells and genetically engineered mouse models. Currently I work on deciphering oncogenic FGFR2 signaling in breast cancer and identification of oncogenic FGFR2 variants in breast and other cancers.